News

Sequana Medical Showcases Innovative alfapump System at Conference

Sequana Medical Showcases Innovative alfapump System at Conference

Sequana Medical Highlights alfapump System at Major Conference

Recently, Sequana Medical NV, an innovative company focused on transforming the treatment landscape for drug-resistant fluid overload, particularly in patients with liver disease and heart failure, made headlines. Their groundbreaking alfapump system was prominently featured at a key medical conference focused on interventional radiology. This event, the Society of Interventional Radiology's SIR EDGE 2025, served as a platform for discussing the latest advancements in medical technology.

Clinical Advantages of the alfapump System

The presentation, intriguingly titled “Not the Alpha Male, the Alfapump!”, elucidated the significant clinical impacts and revolutionary nature of the alfapump technology. Leading the discussion was Dr. Ziv Haskal, a Professor of Radiology and Interventional Radiology at the University of Virginia. He emphasized that the alfapump signifies a major shift in managing refractory ascites, specifically for patients who are not suitable candidates for traditional procedures like TIPS (Transjugular Intrahepatic Portosystemic Shunt). The device provides a continuous, automated solution for removing excess ascitic fluid, freeing patients from the repeated discomfort of paracentesis—a procedure that involves draining fluid from the abdomen.

Insights from Sequana Medical Officials

Dr. Gijs Klarenbeek, the Chief Medical Officer at Sequana Medical, expressed enthusiasm regarding the presentation at SIR EDGE, highlighting the positive reception the alfapump technology received. He noted that the device represents a much-needed modernization in the treatment approach for patients who have struggled with long-standing and often ineffective care. As Sequana Medical prepares for its U.S. commercialization, the team is focused on educating interventional radiologists about how the alfapump can significantly benefit patients.

Regulatory Recognition and Future Plans

Obtaining U.S. FDA Premarket Approval in December 2024 marked a critical milestone for the alfapump system, enabling it to treat recurrent or refractory ascites caused by liver cirrhosis. This distinction makes it the first active implantable medical device of its kind approved in the U.S., capable of automatically and continuously alleviating ascites. In addition, as of October 1, 2025, the alfapump system was granted a New Technology Add-on Payment by CMS for procedures conducted in hospital inpatient settings. With commercial implants expected to roll out in the upcoming months, Sequana Medical is poised to significantly improve patient care in the U.S.

Important Safety Information for alfapump

The alfapump system is designed exclusively for single-patient use among adults afflicted with refractory or recurrent ascites due to liver cirrhosis. Its innovative design allows for efficient removal of excess peritoneal fluid into the bladder, which is subsequently eliminated through normal urination. However, certain contraindications do exist; for instance, it is essential to note that the alfapump is not MRI-safe. This restriction is crucial for patients to understand, as undergoing an MRI could result in significant complications. Moreover, implantation of the alfapump may carry risks such as infection, complications related to the surgical procedure, and adverse effects related to pump functionality.

The Future of Sequana Medical

As a pioneer in addressing severe fluid overload, Sequana Medical continues to focus on enhancing treatment options for patients facing chronic conditions such as liver disease and heart failure. Their proprietary alfapump technology, among others under development, aims to not only reduce the burden of treatment but also to improve quality of life for patients. Currently listed on Euronext Brussels, Sequana Medical is committed to innovating further in this critical field, striving to provide cutting-edge solutions for a patient population that often lacks effective treatment options.

Frequently Asked Questions

What is the alfapump system?

The alfapump system is an active implantable medical device that automatically removes ascitic fluid from the abdomen into the bladder, intended for patients with liver cirrhosis.

How does the alfapump benefit patients?

This device alleviates the need for repetitive paracentesis procedures, enhancing comfort and improving the overall quality of life for patients with refractory ascites.

Who presented at the SIR EDGE 2025 conference?

Dr. Ziv Haskal, a Professor of Radiology, discussed the clinical impacts and innovative solutions offered by the alfapump system during the conference.

What regulatory approval has the alfapump received?

The alfapump system received U.S. FDA Premarket Approval in December 2024, allowing it to be used for treating recurrent or refractory ascites due to liver cirrhosis.

Is the alfapump system available in Canada?

No, the alfapump system is currently not approved for use in Canada.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Norris Lake's New Kayak Fleet Propels Tourism Efforts

Updated Category News Views 157

Norris Lake Doubles Down on Water Adventures The winds of change are paddling through Norris Dam State Park as they've launched a new fleet of shiny kayaks, hoping to lure more adventure seekers into the heart of Tennessee. These ain't just boats; they're part of a bigger play by local tourism honchos hungry to pump some adrenaline—and dollars—back into the area. A...

Continue Reading
AdMaven's Mave AI: Revolutionizing Campaign Management

Updated Category News Views 161

Taking the Tedious Out of Advertising You've got to love it when technology actually makes life easier, rather than more complicated. AdMaven's latest fancy toy, the AI assistant Mave, is promising just that. It's designed to take the heavy lifting off advertisers' shoulders, especially the day-to-day grind of tweaking ad settings and monitoring performance. If you've...

Continue Reading
LA Hospitals Shine in Pulmonary Excellence Nationwide

Updated Category News Views 135

Los Angeles Community Hospitals' Recent Recognition You ever stroll into a hospital and wonder if you’re really getting the best care? Well, the folks over at Los Angeles Community Hospitals, covering LA, Norwalk, and Bellflower, just got a big nod from Healthgrades—yeah, the site everyone's checking to find decent healthcare options. They’ve landed among the top...

Continue Reading
Ross Pools Joins Forces with Florida Panthers in 2026

Updated Category News Views 69

An Unlikely Team-Up: Pools and Hockey Well, here's one for the books: a South Florida pool company hitching its wagon to an NHL team. Ross Pools, the folks who’ve been carving out backyard oases in the sizzling Florida sun for over two decades, are now officially aligned with the Florida Panthers. Yeah, the same Panthers that snatched the Stanley Cup not once but twice...

Continue Reading
Quantum X and Everest Cloud Partner in South Asia Push

Updated Category News Views 87

An Unlikely Alliance for Cutting-Edge Tech You gotta admit, the fusion of a U.S.-based tech outfit with a Nepalese cloud provider wasn't the market move anyone saw coming. But here we are—Quantum X is hitching its quantum computing dreams to Everest Cloud's solid local foothold across six South Asian markets. We're talking Nepal, India, Bangladesh, Bhutan, Sri Lanka,...

Continue Reading
Portillo's Faces Legal Heat: Investor Class Action Filed

Updated Category News Views 183

What’s Eating Portillo's? Ah, once upon a misstep in the land of promising expansion, now we have Portillo's Inc. (NASDAQ: PTLO) neck-deep in legal hot water. Those golden fries and famous sandwiches somehow didn't pave the way for stockholder bliss. Why the turmoil? On an ordinary November morning, the DJS Law Group made it clear: They're rallying the troops for a...

Continue Reading
Scientific Games Joins NCPG’s 2026 Campaign Again

Updated Category News Views 242

Scientific Games Backs Responsible Gaming Again It's another year, and here's Scientific Games once more, guns blazing for a cause that's needed more than a few times over—responsible gambling. Those folks got their hearts in the right place, joining the National Council on Problem Gambling's 2026 Gift Responsibly campaign. Ninth time running, no less! It's like...

Continue Reading
Loyalty Programs Cut $1500 Annually for Consumers

Updated Category News Views 132

Loyalty Programs: An Essential Tool for Households In a world where every dollar counts, retail loyalty programs have become more than just a marketing strategy—they're lifelines for American households scraping through each month. According to fresh research by the Retail Industry Leaders Association (RILA) and conducted by market research leader Circana, these...

Continue Reading
Gwen Stefani Kicks Off OCVIBE's New Concert Hall

Updated Category News Views 217

A Homecoming Steeped in Nostalgia Orange County’s about to do a serious throwback, folks! Gwen Stefani is set to headline the opening concert at OCVIBE's spanking new concert hall in Anaheim on March 17, 2027. Curious choice for their opener? Hardly. This gal's practically woven into the county’s tapestry—her roots run deep here, enough to make even the casual music...

Continue Reading
Crocs to Present at Key Industry Conferences

Updated Category News Views 148

Crocs Set to Step into the Spotlight Alright, if there's one thing about Crocs, Inc. (NASDAQ: CROX) that never fails to surprise, it's how they constantly keep everyone on their toes. The iconic casual footwear brand with its whimsical, love-it-or-hate-it reputation is strapping in for not one but two hefty conferences. They've circled November 19 and December 1, 2026, on...

Continue Reading

Top 5 Most Recently Viewed Articles

GIGABYTE Unveils Compact NVIDIA GeForce RTX 50 Series GPUs

Updated Category News Views 348

GIGABYTE Shines at CES with Revolutionary Graphics Card Launch The latest unveiling from GIGABYTE, a leader in innovative computer hardware, features their NVIDIA GeForce RTX™ 50 Series graphics cards. These models, including the GeForce RTX™ 5090, RTX™ 5090 D, RTX™ 5080, RTX™ 5070 Ti, and RTX™ 5070, promise to elevate gaming and creative experiences...

Continue Reading
EssilorLuxottica's Strategic Share Buyback Announcement Details

Updated Category News Views 246

EssilorLuxottica: Share Buyback Update Disclosure of transactions in own shares EssilorLuxottica has recently informed the public about its share buyback activities, following the authorization from its Annual Shareholders’ Meeting held on April 30, 2024. This initiative reflects the company's commitment to maintaining a healthy and robust stock market presence. Recent...

Continue Reading
Aker BP Announces Ex-Dividend Payment of USD 0.63 Today

Updated Category News Views 185

Understanding Aker BP's Ex-Dividend Payment Aker BP ASA has officially announced that its shares will commence trading ex-dividend today, marking a significant moment for investors. The ex-dividend amount is set at USD 0.63 per share, equivalent to NOK 6.36193. This announcement is crucial for shareholders looking to understand their financial returns from this reputable...

Continue Reading
PL Developments Secures FDA Nod for Omeprazole and Debt Restructure

Updated Category News Views 331

PL Developments Reaches Major Milestones With FDA Approval PL Developments (PLD), a leader in the healthcare sector, recently announced two substantial achievements: the FDA's approval for its Omeprazole OTC ANDA and the successful refinancing of its corporate debt. These milestones mark significant advancements in the company's ongoing efforts to innovate and grow....

Continue Reading
Akari Therapeutics Gears Up for Innovations in ADC Payloads

Updated Category News Views 237

Akari Therapeutics Gears Up for Innovations in ADC Payloads Akari Therapeutics, Plc (NASDAQ: AKTX), is making strides in the oncology biotechnology field, particularly with its progressive advancements in antibody drug conjugates (ADCs). Recently, the company released an insightful segment of the CEO Corner, which provides a comprehensive update on its initiatives and...

Continue Reading